| Literature DB >> 26744346 |
Hyoung Kyu Kim1, Bernd Nilius2, Nari Kim1, Kyung Soo Ko1, Byoung Doo Rhee1, Jin Han3.
Abstract
The heart works without resting, requiring enormous amounts of energy to continuously pump blood throughout the body. Because of its considerable energy requirements, the heart is vulnerable to oxidative stress caused by the generation of endogenous reactive oxygen species (ROS). Therefore, the heart has effective regulatory and adaptive mechanisms to protect against oxidative stress. Inherited or acquired mitochondrial respiratory chain dysfunction disrupts energy metabolism and causes excessive ROS production and oxidative stress. The physiological cardiac response to oxidative stress can strengthen the heart, but pathological cardiac responses or altered regulatory mechanisms can cause heart disease. Therefore, mitochondria-targeted antioxidants have been tested and some are used clinically. In this review, we briefly discuss the role of mitochondrial DNA mutations, mitochondrial dysfunction, and ROS generation in the development of heart disease and recent developments in mitochondria-targeted antioxidants for the treatment of heart disease.Entities:
Keywords: Heart disease; Mitochondrial dysfunction; Mitochondrial medicine; Mitochondrial reactive oxygen species; Oxidative stress
Mesh:
Year: 2016 PMID: 26744346 DOI: 10.1007/112_2015_5004
Source DB: PubMed Journal: Rev Physiol Biochem Pharmacol ISSN: 0303-4240 Impact factor: 5.545